Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,268 signal articles · 40 in last 24h · 115,355 total before filter · latest 2h ago
40last 24h
1786last 7d
298● bullish (7d)
169● bearish (7d)
205publishers
AllMacro317Earnings833M&A103Regulatory25Product16Analyst25
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
How Pfizer’s Higher 2026 Guidance And LITFULO Trial Results At Pfizer (PFE) Have Changed Its Investment Story
Simply Wall St.2d agoneutral
How Pfizer’s Higher 2026 Guidance And LITFULO Trial Results At Pfizer (PFE) Have Changed Its Investment Story

In early August 2026, Pfizer Inc. reported second-quarter results showing revenue of US$15,034 million and a net loss of US$248 million, alongside US$4.30 billion in non-cash intangible asset impairments and a modest increase in full-year 2026 revenue guidance to US$60.50–US$62.50 billion. A key offsetting highlight was the positive Phase 3 data for Pfizer’s autoimmune drug LITFULO in nonsegmental vitiligo, underlining the growing importance of its non-COVID portfolio and broader immunology...

Birkenstock Rallies on Forecast; StubHub Falls on Earnings | Stock Movers
Bloomberg2d agobearishVIDEO
Birkenstock Rallies on Forecast; StubHub Falls on Earnings | Stock Movers

On this episode of Stock Movers: - StubHub (STUB) shares are dropping after the company reported earnings per share for the second quarter that missed the average analyst estimate. - Birkenstock (BIRK) is rallying after the footwear maker boosted its adjusted Ebitda forecast for the full year. The German company also reported better-than-expected sales for the second quarter. - Cerebras (CBRS) is lower after the company projected slower growth than some investors anticipated, causing its shares to fall in premarket trading.

Cerebras stock falls on earnings disappointment despite guidance raise
Proactive2d agobearish
Cerebras stock falls on earnings disappointment despite guidance raise

Cerebras Systems Inc (NASDAQ:CBRS) shares fell 11% Thursday after the AI chipmaker reported second-quarter revenue below Wall Street estimates, even as the company raised its full-year guidance. The company posted second-quarter revenue of $180.1 million, missing the $194 million analyst...

Brookfield Asset Management (TSX:BAM) Stock Looks Fully Priced While Earnings Still Support It
Simply Wall St.2d agoneutral
Brookfield Asset Management (TSX:BAM) Stock Looks Fully Priced While Earnings Still Support It

Brookfield Asset Management stock has delivered an 84.2% gain over the past three years, yet current valuation checks suggest the shares are closer to fairly priced than clearly cheap, with the Excess Returns intrinsic value sitting near the market level. The 84.2% return over three years points to strong wealth creation for longer term holders. New buyers now face a very different entry point compared to a few years ago. Brookfield Asset Management's role in large scale AI infrastructure...

Broadcom (AVGO) Stock Trades Near Fair Value But At A Premium On Earnings
Simply Wall St.2d agoneutral
Broadcom (AVGO) Stock Trades Near Fair Value But At A Premium On Earnings

Broadcom stock has delivered a very large 5 year gain yet current checks suggest it is no longer obviously cheap, with a Discounted Cash Flow (DCF) estimate close to the market price while earnings based multiples point to a richer valuation. Broadcom has returned about 8.7x over 5 years, which sets a high bar for any further upside case. Heavy investment in hyperscale AI chips and long term custom silicon agreements can support cash flow expectations, while rising competition in custom AI...